tm logo

Monitor this mark

View On USPTO

YGALO
Dead/Cancelled
CANCELLED – SECTION 71

on 21 Jul 2023

Last Applicant/ Owned by

Oncopeptides AB

SE-111 53 STOCKHOLM

SE

Serial Number

79179189 filed on 19th Nov 2015

Registration Number

5116441 registered on 10th Jan 2017

in the Principal Register

Correspondent Address

John C. McElwaine

John C. McElwaine Nelson Mullins Riley & Scarborough LLP

42nd Floor, IP Department

Charlotte, NC 28202

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

YGALO

pharmaceutical, medicinal and veterinary preparations for the treatment of cancer, neoplastic diseases and multiple myeloma

Classification Information

Class [005]
Pharmaceutical Products

pharmaceutical, medicinal and veterinary preparations for the treatment of cancer, neoplastic diseases and multiple myeloma

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79179189

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 45264/09002

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
22nd Apr 2024TOTAL INVALIDATION PROCESSED BY THE IB
02th Apr 2024INVALIDATION PROCESSED
02th Apr 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
21st Mar 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
21st Jul 2023CANCELLED SECTION 71
10th Jan 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
21st Sep 2017NEW REPRESENTATIVE AT IB RECEIVED
28th Apr 2017NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
28th Apr 2017FINAL DECISION TRANSACTION PROCESSED BY IB
12th Apr 2017FINAL DISPOSITION NOTICE SENT TO IB